Marcus Renner

Title: The Innovations of Marcus Renner

Introduction

Marcus Renner is a notable inventor based in Leimen, Germany. He has made significant contributions to the field of medicine through his innovative research and patents. His work focuses on the use of DMBT1 for capturing sulphate and phosphate group exposing agents, which has implications for treating various diseases.

Latest Patents

Renner holds a patent titled "Use of DMBT1 for capturing sulphate and phosphate group exposing agents." This patent discloses the use of DMBT1, or the nucleic acid encoding it, for the manufacture of a medicament aimed at treating patients suffering from diseases caused by agents with accessible sulphate and/or phosphate groups. Additionally, it outlines the uses of DMBT1 as a diagnostic tool for assessing an individual's susceptibility to these groups, along with methods for diagnosis, prophylaxis, or treatment of related diseases. He has 1 patent to his name.

Career Highlights

Throughout his career, Marcus Renner has worked with esteemed organizations, including Deutsches Krebsforschungszentrum and Mollenhauer. His experience in these institutions has allowed him to collaborate with other professionals and contribute to groundbreaking research in his field.

Collaborations

Renner has collaborated with notable coworkers such as Jan Mollenhauer and Caroline End. Their combined expertise has furthered the advancements in the applications of DMBT1 and its potential benefits in medical treatments.

Conclusion

Marcus Renner's innovative work in the field of medicine, particularly through his patent on DMBT1, showcases his dedication to improving patient care. His contributions are significant and continue to influence the medical community.